热门出版物 - 学术资源搜索

h5 指数:39
h5 中位数:48

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#14 Medicinal Chemistry

标题/作者	引用次数	年份
Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017) X Zuo, Z Huo, D Kang, G Wu, Z Zhou, X Liu, P Zhan Expert Opinion on Therapeutic Patents 28 (4), 299-316	286	2018
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015) P Kosikowska, A Lesner Expert Opinion on Therapeutic Patents 26 (6), 689-702	87	2016
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018) A Nocentini, CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 729-740	78	2018
Potential pharmacological uses of chalcones: a patent review (from June 2011–2014) MJ Matos, S Vazquez-Rodriguez, E Uriarte, L Santana Expert Opinion on Therapeutic Patents 25 (3), 351-366	68	2015
Taxane anticancer agents: a patent perspective I Ojima, B Lichtenthal, S Lee, C Wang, X Wang Expert Opinion on Therapeutic Patents 26 (1), 1-20	68	2016
Schiff bases in medicinal chemistry: a patent review (2010-2015) A Hameed, M al-Rashida, M Uroos, S Abid Ali, KM Khan Expert Opinion on Therapeutic Patents 27 (1), 63-79	66	2017
Novel monoamine oxidase inhibitors: a patent review (2012–2014) S Carradori, JP Petzer Expert Opinion on Therapeutic Patents 25 (1), 91-110	65	2015
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 709-712	63	2018
Pharmacological effects of berberine and its derivatives: a patent update Y Jin, DB Khadka, WJ Cho Expert Opinion on Therapeutic Patents 26 (2), 229-243	62	2016
A decade of nutraceutical patents: where are we now in 2018? P Daliu, A Santini, E Novellino Expert Opinion on Therapeutic Patents 28 (12), 875-882	59	2018
Transient receptor potential vanilloid type 1 antagonists: a patent review (2011–2014) Y Lee, S Hong, M Cui, PK Sharma, J Lee, S Choi Expert Opinion on Therapeutic Patents 25 (3), 291-318	57	2015
Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 713-721	56	2018
Therapeutic potential of benzothiazoles: a patent review (2010–2014) A Kamal, MAH Syed, SM Mohammed Expert Opinion on Therapeutic Patents 25 (3), 335-349	55	2015
RORγ antagonists and inverse agonists: a patent review SM Bronner, JR Zbieg, JJ Crawford Expert Opinion on Therapeutic Patents 27 (1), 101-112	55	2017
Deubiquitinases (DUBs) and DUB inhibitors: a patent review P Farshi, RR Deshmukh, JO Nwankwo, RT Arkwright, B Cvek, J Liu, ... Expert Opinion on Therapeutic Patents 25 (10), 1191-1208	54	2015
Topical drug delivery systems: a patent review D Singh Malik, N Mital, G Kaur Expert Opinion on Therapeutic Patents 26 (2), 213-228	53	2016
Sulfonamide inhibitors: a patent review 2013-present İ Gulçin, P Taslimi Expert Opinion on Therapeutic Patents 28 (7), 541-549	50	2018
Therapeutic effects of EGCG: a patent review L Chakrawarti, R Agrawal, S Dang, S Gupta, R Gabrani Expert Opinion on Therapeutic Patents 26 (8), 907-916	50	2016
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015) T Zarganes-Tzitzikas, M Konstantinidou, Y Gao, D Krzemien, K Zak, ... Expert Opinion on Therapeutic Patents 26 (9), 973-977	49	2016
c-Jun N-terminal kinase inhibitors: a patent review (2010–2014) M Gehringer, F Muth, P Koch, SA Laufer Expert Opinion on Therapeutic Patents 25 (8), 849-872	48	2015

1 - 20

计算机程序会自动估算并确定日期和引用次数。